These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15169706)

  • 21. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study.
    Troost PW; Lahuis BE; Steenhuis MP; Ketelaars CE; Buitelaar JK; van Engeland H; Scahill L; Minderaa RB; Hoekstra PJ
    J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1137-44. PubMed ID: 16239862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Six months of treatment with risperidone may be associated with nonsignificant abnormalities of liver function tests in children and adolescents: a longitudinal, observational study from Turkey.
    Erdogan A; Karaman MG; Ozdemir E; Yurteri N; Tufan AE; Kurcer MA
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):407-13. PubMed ID: 20973711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy.
    Luby J; Mrakotsky C; Stalets MM; Belden A; Heffelfinger A; Williams M; Spitznagel E
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):575-87. PubMed ID: 17069546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 3-year naturalistic study of 53 preschool children with pervasive developmental disorders treated with risperidone.
    Masi G; Cosenza A; Mucci M; Brovedani P
    J Clin Psychiatry; 2003 Sep; 64(9):1039-47. PubMed ID: 14628979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months.
    Kelly DL; Conley RR; Love RC; Horn DS; Ushchak CM
    J Child Adolesc Psychopharmacol; 1998; 8(3):151-9. PubMed ID: 9853689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder.
    Scahill L; Jeon S; Boorin SJ; McDougle CJ; Aman MG; Dziura J; McCracken JT; Caprio S; Arnold LE; Nicol G; Deng Y; Challa SA; Vitiello B
    J Am Acad Child Adolesc Psychiatry; 2016 May; 55(5):415-23. PubMed ID: 27126856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
    Prescrire Int; 2006 Apr; 15(82):43-5. PubMed ID: 16602211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leptin gene -2548G/A variants predict risperidone-associated weight gain in children and adolescents.
    Calarge CA; Ellingrod VL; Zimmerman B; Acion L; Sivitz WI; Schlechte JA
    Psychiatr Genet; 2009 Dec; 19(6):320-7. PubMed ID: 19873684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body mass index changes and chronic neuroleptic drug treatment for Tourette syndrome.
    Degrauw RS; Li JZ; Gilbert DL
    Pediatr Neurol; 2009 Sep; 41(3):183-6. PubMed ID: 19664533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of behavioral disorders by risperidone in children with autism].
    Wei BY; Huang F; Qin XT; Liang QQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Mar; 13(3):216-8. PubMed ID: 21426640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron homeostasis during risperidone treatment in children and adolescents.
    Calarge CA; Ziegler EE; Del Castillo N; Aman M; McDougle CJ; Scahill L; McCracken JT; Arnold LE
    J Clin Psychiatry; 2015 Nov; 76(11):1500-5. PubMed ID: 26301448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Open trial of risperidone in 24 young children with pervasive developmental disorders.
    Masi G; Cosenza A; Mucci M; Brovedani P
    J Am Acad Child Adolesc Psychiatry; 2001 Oct; 40(10):1206-14. PubMed ID: 11589534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship of changes in leptin, neuropeptide Y and reproductive hormones to antipsychotic induced weight gain.
    Fitzgerald PB; Scaffidi A; Morris MJ; de Castella AR; Kulkarni J
    Hum Psychopharmacol; 2003 Oct; 18(7):551-7. PubMed ID: 14533137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weight-Change Trajectories of Pediatric Outpatients Treated with Risperidone or Aripiprazole in a Naturalistic Setting.
    Pozzi M; Pisano S; Marano G; Carnovale C; Bravaccio C; Rafaniello C; Capuano A; Rossi F; Rizzo R; Bernardini R; Nobile M; Molteni M; Clementi E; Biganzoli E; Radice S
    J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):133-140. PubMed ID: 30452281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ghrelin and leptin response to oral glucose challenge among antipsychotic drug-treated children.
    Winsberg B; Usubiaga H; Cooper T
    J Clin Psychopharmacol; 2007 Dec; 27(6):590-4. PubMed ID: 18004125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of risperidone in children with autism spectrum disorder.
    Chavez B; Chavez-Brown M; Rey JA
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An open trial of risperidone in young autistic children.
    Nicolson R; Awad G; Sloman L
    J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):372-6. PubMed ID: 9549957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Risperidone use in child and adolescent psychiatric patients].
    Chevreuil C; Reymann JM; Frémaux T; Polard E; Séveno T; Bentué-Ferrer D
    Therapie; 2008; 63(5):359-75. PubMed ID: 19154706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Weight changes and their associations with demographic and clinical characteristics in risperidone maintenance treatment for schizophrenia.
    Xiang YT; Wang CY; Ungvari GS; Kreyenbuhl JA; Chiu HF; Lai KY; Lee EH; Bo QJ; Dixon LB
    Pharmacopsychiatry; 2011 Jun; 44(4):135-41. PubMed ID: 21710403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.